NYSEAMERICAN:IBO Impact Biomedical Q2 2026 Earnings Results & Report $4.25 +0.14 (+3.41%) Closing price 10/9/2026 04:10 PM EasternExtended Trading$4.28 +0.03 (+0.59%) As of 10/9/2026 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Impact Biomedical reported Q2 2026 earnings on August 7, 2026. The company reported EPS of -$0.1262, while revenue was $0.00 million. Research:ProfileEarnings History Earnings Announcement Details QuarterQ2 2026Report DateAugust 7, 2026TimeBefore Market OpensConference Call7:00 AM ET Impact Biomedical EPS ResultsActual EPS-$0.1262Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AImpact Biomedical Revenue ResultsActual Revenue$0.00 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesQuarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) Impact Biomedical Q2 2026 Earnings FAQ Did Impact Biomedical beat earnings estimates for Q2 2026? Impact Biomedical (NYSEAMERICAN:IBO) reported earnings of -$0.1262 per share for Q2 2026. The report was announced on Friday, August 7, 2026. What was Impact Biomedical's revenue for Q2 2026? Impact Biomedical reported revenue of $0.00 million for Q2 2026. Impact Biomedical Earnings HeadlinesImpact BioMedical advances merger with Zoar LimitedSeptember 17, 2026 | tipranks.comImpact Biomedical Files Form F-4 For Proposed Zoar Business CombinationSeptember 16, 2026 | rttnews.comLook at Elon’s face after meeting with ChinaElon Musk recently met with Chinese President Xi Jinping, and a former Wall Street Journal Personal Finance Expert says the agenda could have major implications for the U.S. economy. The analysis outlines five steps Americans may want to consider before November 12, 2026. | International Living (Ad)Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)September 16, 2026 | finance.yahoo.comImpact Biomedical Inc. Announces Filing of F-4 Registration Statement for Proposed Business Combination with Zoar LimitedSeptember 16, 2026 | quiverquant.comQImpact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley's Limited)September 16, 2026 | globenewswire.comSee More Impact Biomedical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Impact Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Impact Biomedical and other key companies, straight to your email. Email Address About Impact BiomedicalImpact Biomedical (NYSEAMERICAN:IBO), Inc. is a biotechnology and life sciences company focused on developing and commercializing biomedical technologies, pharmaceutical products and related health solutions. Its activities have included research into antiviral, antimicrobial and anti-inflammatory applications, with an emphasis on technologies intended to address infectious diseases and other public health needs. The company has described a portfolio of biomedical intellectual property and development programs rather than a broad portfolio of established commercial products. Its work has included potential therapeutics, preventive technologies and other health-related applications developed independently or through research and commercialization relationships. Impact Biomedical is publicly traded on the NYSE American under the symbol IBO. Publicly available information about its operating geographies, commercial scale and current leadership is limited, and the company appears to remain primarily focused on research, development and the potential commercialization of its technology portfolio.View Impact Biomedical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part BeginsSkydance Just Became a Media Giant—With an $80 Billion Debt Load Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
